New preprint: "PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial" with Mike Pickles, @dr_anne_cori@p_robot and friends. 1/n medrxiv.org/content/10.110…
A few years we found we needed an agent based model to simulate interventions against the HIV pandemic in southern Africa, and ended up developing a new one. We found that with heterogeneities and detailed interventions, ABMs were more parsimonious than compartmental models. 2/n
So we set out to develop a model that was, to paraphrase, "as simple as necessary, but no simpler". We wanted it to be computationally efficient so as to be able to do parameter sweeps and inference. Here it is 3/n github.com/BDI-pathogens/…
It simulates what we think we needed. A lot of parameters and computations are linked to the dynamic sexual network. 4/n
It's pretty nifty on a laptop. 5/n
You can do Bayesian fitting to a whole lot of summary statistics 6/n.
Epidemic curves describe the epidemic in the communities where we working in Zambia and South Africa. The numbers are always quite shocking. 7/n
The model simulates individual transmission events, and the best fit epidemics have an interesting mix of transmission types, with two visible tempi of transmission. Clusters of rapid transmission, interspersed with long periods before the next cluster. 8/n
The model has limitations. Only heterosexual transmission is modelled. There are no key populations. 9/n
Recently, Rob Hinch has been re-coding to make it easier to make changes. Some of the coding concepts have made it into our COVID-19 simulator. 10/n github.com/BDI-pathogens/…
The work was done together with many wonderful collaborators from the HPTN 071 PopART trial 11/n nejm.org/doi/full/10.10…
Coming soon: to test the predictive ability of the model, we posted predictions from the model before the trial was unblinded. We will publish this alongside some learnings from re-fitting the model to the trial outcome. 12/end
Postscript 1: we welcome collaboration on using & extending this model. Our recent experience with OpenABM-Covid-19 shows that with generic network simulation, custom transmission and interventions, and a strong unit testing framework, this code is ready for collaboration. 13/12
• • •
Missing some Tweet in this thread? You can try to
force a refresh
“England 'risks Covid-19 surge' without test-and-trace safety net” I agree, and am concerned about rapid easing of lockdown. 1/n. theguardian.com/world/2020/may…
The ONS reports around 8,000 new infections per day, and that has not been declining quickly. 2/n ons.gov.uk/peoplepopulati…
The central estimate for the number people positive for currently shedding virus is 148,000 people for 27 April to 10 May, 137,000 people for 4 May to 17 May and 133,000 people for 11 May to 24 May. This indicates R very close to 1 during May. 3/n ons.gov.uk/peoplepopulati…
Digital contact tracing may contribute to epidemic suppression of COVID. What are the trade-offs in choosing centralised or decentralised systems? . 1/n
There are three broad aims to be optimised: prevention of infection and disease, minimisation of disruptive requests to isolate, and maximisation of privacy. 2/n
A clear assessment requires acknowledging that we don't know as much as we’d like about the details of how this virus spreads. And nor do we know enough about the context of how this intervention fits in broader public health measures that will get us safely out of lockdown. 3/n
Isolation, contact tracing, and quarantine are proven methods of infection control, but for COVID-19 conventional tracing is too slow. 50% of transmissions happen before symptoms, so the epidemic is always a step ahead. 2/
Because it is near instantaneous, digital contact tracing changes that: if people install an app that ‘remembers’ contacts for them, and those contacts are instantly notified on diagnosis, this cuts a week of the whole process of contact tracing. 3/
"Sustainable containment of COVID-19 using smartphones in China: Scientific and ethical underpinnings for implementation of similar approaches in other settings"
Discussions emphasising 'COVID19 is more serious than flu' will probably become moot in the coming days and weeks, and for many people already have, but in case you are engaged in them, I would consider trying to get accurate numbers for flu, and to make some general points. 1/n
First off, flu mortality is sufficiently low that it is hard to measure, and requires a degree of modelling just to get at. That in itself tells you something. 2/n
Second, the vast majority of flu cases are not reported or diagnosed, so data are pieced together from various surveillance systems and studies. 3/n